0001179110-13-013100.txt : 20130813 0001179110-13-013100.hdr.sgml : 20130813 20130813181002 ACCESSION NUMBER: 0001179110-13-013100 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130802 FILED AS OF DATE: 20130813 DATE AS OF CHANGE: 20130813 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Actavis, Inc. CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: WATSON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olafsson Sigurdur O CENTRAL INDEX KEY: 0001499481 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 131034313 MAIL ADDRESS: STREET 1: 360 MOUNT KEMBLE AVENUE CITY: MORRISTOWN STATE: NJ ZIP: 07960 4/A 1 edgar.xml FORM 4/A - X0306 4/A 2013-08-02 2013-08-06 0 0000884629 Actavis, Inc. ACT 0001499481 Olafsson Sigurdur O MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 0 1 0 0 Pres-Global Generics Common Stock, par value $0.0033 2013-08-02 4 S 0 4500 135.4661 D 84643 D Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended. This amendment to Form 4 is filed solely to correct the transaction code in Box 3 to reflect a sale rather than a forteiture of shares on the transaction date. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.27 to $135.69, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder to Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. SIGURDUR O OLAFSSON 2013-08-13